faculty photo

Mary Ann Thenganatt, MD

Penn Medicine Clinician of Neurology
Department: Neurology

Contact information
BA, MD (Medical Science, Medicine)
Boston University, 2006.
Post-Graduate Training
Intern, Internal Medicine, UCLA Medical Center, 2006-2007.
Resident, Neurology, Columbia University Medical Center, 2007-2010.
Movement Disorders Fellow, Neurology, Columbia University Medical Center, 2010-2012.
American Board of Psychiatry and Neurology, 2010.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Thenganatt MA, Jankovic J: The relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord Suppl 1: S162-5, Jan 2016.

Thenganatt MA, Jankovic J: Psychogenic Parkinsonism. Functional Neurological Disorders, Handbook of Neurology 2016 Notes: In press.

Thenganatt MA, Jankovic J: Botulinum toxin therapy for cervical dystonia. Treatment of Dystonia. Dressler D, Altenmuller E and Krauss J (eds.). 2016 Notes: In progress.

Thenganatt MA, Jankovic J: Recent advances in understanding/managing Tourette’s Syndrome F1000Res 592, August 2015.

Thenganatt MA, Jankovic J: Psychogenic movement disorders. Neurol Clin 33(1): 205-224, Feb 2015.

Thenganatt MA, Jankovic J : Parkinson Disease Subtypes. JAMA Neurol 71(4): 499-504, Apr 2014.

Thenganatt MA, Jankovic J : Treatment of dystonia. Neurotherapeutics 11(1): 139-52, Jan 2014.

Thenganatt MA, Louis ED: Personality profile in essential tremor: A case- control study. Parkinsonism Relat Disord 18(9): 1042-4, Nov 2012.

Thenganatt MA, Louis ED: Distinguishing essential tremor from Parkinson's disease: bedside tests and laboratory evaluations. Expert Rev Neurother 12(6): 687-96, Jun 2012.

Botulinum toxin for the treatment of movement disorders: Thenganatt MA, Fahn S. Curr Neurol Neurosci Rep 12(4): 399-409, Aug 2012.

back to top
Last updated: 03/14/2017
The Trustees of the University of Pennsylvania